# Study of Testosterone and Athlete Response

> **NCT03210558** · PHASE2 · COMPLETED · sponsor: **Karolinska University Hospital** · enrollment: 48 (actual)

## Conditions studied

- Athletic Performance
- Testosterone
- Women's Health: Female Athlete/Female Athlete Triad

## Interventions

- **DRUG:** Testosterone cream 1% (Andro-Feme® )
- **DRUG:** Placebo cream

## Key facts

- **NCT ID:** NCT03210558
- **Lead sponsor:** Karolinska University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-26
- **Primary completion:** 2018-06-20
- **Final completion:** 2018-06-20
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2022-10-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03210558

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03210558, "Study of Testosterone and Athlete Response". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03210558. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*